ANI Pharmaceuticals Inc (ANIP) Insider Trading
- $2,005,711.60
- $144,160,208.13
- March 13, 2026
- Muthusamy Shanmugam
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| July 17, 2023 | COO | 9,831 | $51.06 | Sell | $501,970.86 | |
| July 14, 2023 | COO | 10,000 | $50.43 | Sell | $504,300.00 | |
| July 3, 2023 | SVP | 20,000 | $53.43 | Sell | $1,068,600.00 | |
| June 22, 2023 | SVP | 20,000 | $51.32 | Sell | $1,026,400.00 | |
| June 22, 2023 | COO | 13,500 | $51.38 | Sell | $693,630.00 | |
| June 20, 2023 | COO | 14,657 | $51.93 | Sell | $761,138.01 | |
| Aug. 15, 2022 | SVP | 5,172 | $37.79 | Sell | $195,449.88 | |
| Aug. 12, 2022 | SVP | 12,894 | $37.04 | Sell | $477,593.76 | |
| March 21, 2022 | CEO | 7,224 | $27.69 | Buy | $200,032.56 | |
| March 21, 2022 | Director | 5,000 | $27.76 | Buy | $138,800.00 | |
| March 17, 2022 | COO | 5,000 | $27.65 | Buy | $138,250.00 | |
| Dec. 20, 2021 | Director | 1,072 | $46.47 | Buy | $49,815.84 | |
| Dec. 6, 2021 | Director | 2,500 | $39.38 | Buy | $98,450.00 | |
| March 15, 2021 | Director | 4,000 | $32.89 | Buy | $131,560.00 | |
| Nov. 9, 2020 | Director | 5,000 | $25.96 | Buy | $129,800.00 | |
| Aug. 10, 2020 | CEO | 10,000 | $30.78 | Buy | $307,800.00 | |
| March 3, 2020 | Director | 2,000 | $45.18 | Buy | $90,360.00 | |
| Aug. 20, 2019 | Major Shareholder | 7,579 | $68.21 | Sell | $516,963.59 | |
| Aug. 15, 2019 | Major Shareholder | 9,315 | $69.34 | Sell | $645,902.10 | |
| Aug. 13, 2019 | Major Shareholder | 61,697 | $71.64 | Sell | $4,419,973.08 | |
| Aug. 9, 2019 | Major Shareholder | 19,860 | $71.70 | Sell | $1,423,962.00 | |
| May 24, 2019 | Director | 1,445 | $68.76 | Buy | $99,358.20 | |
| May 17, 2019 | SVP | 8,907 | $70.67 | Sell | $629,457.69 | |
| May 15, 2019 | Insider | 30,000 | $70.07 | Sell | $2,102,100.00 | |
| May 15, 2019 | Director | 2,500 | $69.30 | Buy | $173,250.00 | |
| May 13, 2019 | CEO | 9,595 | $71.10 | Sell | $682,204.50 | |
| May 13, 2019 | SVP | 2,409 | $71.13 | Sell | $171,352.17 | |
| March 19, 2019 | Insider | 27,625 | $63.53 | Sell | $1,755,016.25 | |
| March 13, 2019 | SVP | 4,651 | $64.43 | Sell | $299,663.93 | |
| May 16, 2018 | Director | 38,236 | $62.33 | Sell | $2,383,249.88 | |
| May 10, 2018 | Director | 62,431 | $62.07 | Sell | $3,875,092.17 | |
| April 18, 2018 | Director | 33,200 | $62.09 | Sell | $2,061,388.00 | |
| March 19, 2018 | Director | 7,215 | $60.85 | Sell | $439,032.75 | |
| March 14, 2018 | Director | 27,964 | $62.24 | Sell | $1,740,479.36 | |
| March 14, 2018 | Insider | 40,000 | $61.83 | Sell | $2,473,200.00 | |
| March 12, 2018 | Director | 64,221 | $63.03 | Sell | $4,047,849.63 | |
| March 8, 2018 | Director | 15,391 | $63.08 | Sell | $970,864.28 | |
| March 5, 2018 | SVP | 4,177 | $61.92 | Sell | $258,639.84 | |
| March 1, 2018 | SVP | 28,652 | $61.66 | Sell | $1,766,682.32 | |
| Aug. 22, 2016 | Insider | 37,455 | $66.97 | Sell | $2,508,361.35 | |
| Aug. 8, 2016 | VP | 12,500 | $67.06 | Sell | $838,250.00 | |
| Dec. 18, 2015 | VP | 3,500 | $43.26 | Sell | $151,410.00 | |
| Nov. 12, 2015 | CEO | 2,500 | $40.95 | Buy | $102,375.00 | |
| March 19, 2015 | VP | 15,000 | $66.50 | Sell | $997,500.00 | |
| Sept. 15, 2014 | Director | 3,000 | $27.49 | Buy | $82,470.00 | |
| Sept. 9, 2014 | CEO | 1,000 | $26.50 | Buy | $26,500.00 | |
| June 18, 2014 | VP | 5,000 | $34.28 | Sell | $171,400.00 | |
| May 8, 2014 | Director | 1,381 | $30.02 | Sell | $41,457.62 | |
| May 7, 2014 | Director | 2,000 | $30.38 | Buy | $60,760.00 | |
| March 21, 2014 | Director | 21,767 | $31.42 | Sell | $683,919.14 |
Insiders are both buying and selling ANI Pharmaceuticals Inc stock.
The insider traders at ANI Pharmaceuticals Inc are: Muthusamy Shanmugam, Meredith Cook, Chad Gassert, Tracy Marshbanks, James G Marken, Meridian Venture Partners Ii L, Nikhil Lalwani, Krista Davis, Arthur Przybyl, Stephen P Carey, Christopher Mutz, Ori Gutwerg, Patrick D Walsh, Robert W Schrepfer, Thomas Haughey, Antonio R Pera, Ross J Mangano, Thomas Andrew Rowland, Matthew J Leonard, Daniel Raynor, Jeanne Thoma, David Nash, Ross Mangano, and Renee P Tannenbaum
The most active insider trader at ANI Pharmaceuticals Inc is Muthusamy Shanmugam with 36 trades.
Muthusamy Shanmugam has sold the most ANI Pharmaceuticals Inc stock with a total value of $45,394,142.03.
Patrick D Walsh has bought the most ANI Pharmaceuticals Inc stock with a total value of $846,760.00.
The most recent insider trade for ANI Pharmaceuticals Inc was on March 13, 2026.
The single biggest insider buy for ANI Pharmaceuticals Inc was from Patrick D Walsh with a total value of $307,800.00 on Aug. 10, 2020.
The single biggest insider sell for ANI Pharmaceuticals Inc was from Meridian Venture Partners Ii L with a total value of $11,700,000.00 on Aug. 16, 2023.
